STAT+

STAT+ is STAT’s premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond. Learn more.

All Coverage

Health Tech Mohana Ravindranath

One Medical founder Tom Lee on the Amazon deal and striking the right balance with virtual care

Biotech Allison DeAngelis

Once a small player among biotech VCs, Mubadala Capital Ventures is punching above its weight

Pharma Tara Bannow

In a new lawsuit, pharma-backed patient groups fight federal rule around copay coupons

Pharmalot Allison DeAngelis

Pharmalittle: FDA expected to authorize new Covid-19 boosters; Biden administration signs a deal to support monkeypox vaccine manufacturing

Pharmalot Allison DeAngelis

Pharmalittle: The ‘godfather’ of biotech trying to save Biogen; pharma companies grapple with ADHD drug shortages

Business Bob Herman

As medical device companies look to snap up Medicare dollars, potential conflicts lurk

Pharmalot Ed Silverman

Up and down the ladder: The latest comings and goings

Pharmalot Ed Silverman

Pharmalittle: Moderna sues Pfizer over Covid-19 vax patents; White House directs quick access to federally funded research

Pharmalot Ed Silverman

Centene agrees to pay $33 million to resolve another state probe into its pharmacy benefits business

Pharmalot Ed Silverman

Pharmalittle: House report shows Trump sought to pressure FDA on Covid response; Pfizer Covid pill provides little benefit to younger adults

Pharmalot Ed Silverman

Pharmalittle: AstraZeneca may exit the vaccine business; Bavarian Nordic looks at expired monkeypox vax doses to boost supplies

Biotech Jason Mast

How a long-overlooked protein could remake neuroscience drug discovery — or plunge the FDA into controversy

Pharmalot Ed Silverman

Pharmalittle: Biden plan to stretch monkeypox vax supplies hits problems; Pfizer and BioNTech ask FDA to clear Covid shot for variants

Biotech Isabella Cueto

Faster drug approval route sparks investment in rare kidney disease treatments

Opinions+ Preston Toole

How machine learning and automation can solve biomanufacturing scale-up challenges

Pharmalot Ed Silverman

Pharmalittle: Murky online market for abortion pills is thriving; more ‘cash pay’ pharmacies decline insurance in the U.S.

Hospitals Tara Bannow

Biden administration largely stands firm on its method for resolving surprise billing disputes

Pharmalot Ed Silverman

FDA scolds Sun Pharma for allegedly backdating documents and fudging records for collecting drug samples

Pharmalot Ed Silverman

Up and down the ladder: The latest comings and goings

Biotech Damian Garde

FDA approves Axsome’s fast-acting treatment for major depression

Pharmalot Ed Silverman

Pharmalittle: Biden plan to shift cost of Covid-19 products to consumers; U.S. company to help with monkeypox shot production

Pharmalot Ed Silverman

Medicare may eventually negotiate some drug prices, but Colorado still wants to import medicines from Canada

Biotech Ryan Cross — The Boston Globe

‘We’re finally here’: Harvard graduate spearheads custom gene therapy for younger brother

Pharmalot Ed Silverman

Pharmalittle: FDA approves a gene therapy for a rare blood disorder; pharmacy chains ordered to pay $650 million over opioid crisis

Politics Rachel Cohrs

STAT+

Most Read

Fed up with costly, onerous recertification, doctors are turning to an alternative board

For the ‘godfather’ of biotech, saving Biogen is the final act of a singular career

Moderna’s suing Pfizer? Wow! OK, now take a deep breath.

Why Amazon and other corporate giants are in a bidding war for home health technology

Pfizer’s experimental RSV vaccine protects older adults in study

OrbiMed tumbles from the top of STAT’s biotech venture capital performance ranking

Major Indian generic drugmaker closes a U.S. facility after years of manufacturing problems

How North Carolina hospitals justify thwarting Medicaid expansion

All Coverage

One Medical founder Tom Lee on the Amazon deal and striking the right balance with virtual care

Once a small player among biotech VCs, Mubadala Capital Ventures is punching above its weight

In a new lawsuit, pharma-backed patient groups fight federal rule around copay coupons

Pharmalittle: FDA expected to authorize new Covid-19 boosters; Biden administration signs a deal to support monkeypox vaccine manufacturing

Pharmalittle: The ‘godfather’ of biotech trying to save Biogen; pharma companies grapple with ADHD drug shortages

As medical device companies look to snap up Medicare dollars, potential conflicts lurk

Up and down the ladder: The latest comings and goings

Pharmalittle: Moderna sues Pfizer over Covid-19 vax patents; White House directs quick access to federally funded research

Centene agrees to pay $33 million to resolve another state probe into its pharmacy benefits business

Pharmalittle: House report shows Trump sought to pressure FDA on Covid response; Pfizer Covid pill provides little benefit to younger adults

Pharmalittle: AstraZeneca may exit the vaccine business; Bavarian Nordic looks at expired monkeypox vax doses to boost supplies

How a long-overlooked protein could remake neuroscience drug discovery — or plunge the FDA into controversy

Pharmalittle: Biden plan to stretch monkeypox vax supplies hits problems; Pfizer and BioNTech ask FDA to clear Covid shot for variants

Faster drug approval route sparks investment in rare kidney disease treatments

How machine learning and automation can solve biomanufacturing scale-up challenges

Pharmalittle: Murky online market for abortion pills is thriving; more ‘cash pay’ pharmacies decline insurance in the U.S.

Biden administration largely stands firm on its method for resolving surprise billing disputes

FDA scolds Sun Pharma for allegedly backdating documents and fudging records for collecting drug samples

Up and down the ladder: The latest comings and goings

FDA approves Axsome’s fast-acting treatment for major depression

Pharmalittle: Biden plan to shift cost of Covid-19 products to consumers; U.S. company to help with monkeypox shot production

Medicare may eventually negotiate some drug prices, but Colorado still wants to import medicines from Canada

‘We’re finally here’: Harvard graduate spearheads custom gene therapy for younger brother

Pharmalittle: FDA approves a gene therapy for a rare blood disorder; pharmacy chains ordered to pay $650 million over opioid crisis

Pharma’s likely to sue over Medicare negotiation. Here are the arguments they might use

You've been selected! STAT+ for less than $2/day

Subscribe to STAT+ for less than $2 per day